Purchase Order 75D30119P05039
Award Date 6/24/19
Potential Completion Date 8/31/20
Potential Value $220K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
- This federal contract award, valued at $85,272.00, was issued by the Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract is for research services related to "TRUE DIABETES INCIDENCE AND DETECTION IN THE U.S. ADULT PUPLATION." This appears to be a prime contract with no set-aside designation. The services provided include compartment modeling, risk score analysis, and projections on the...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the prevalence of late diabetes in Pima Indians in the United States. The contract is a firm fixed-price purchase order with a potential value of $147,876.39 and a completion date of September 29, 2018. Deutsche Diabetes...
- This is a $147,470.09 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Baker Heart and Diabetes Institute, a non-profit medical research facility based in Australia. The contract was for research on global and country-specific trends in the incidence of Type 2 diabetes. The contract did not have a set-aside designation. The Baker Heart and Diabetes Institute has previously performed research services as a subcontractor on federal...
- The Centers for Disease Control and Prevention (CDC) awarded a $78,743 firm fixed price purchase order to Biocentric, Inc. to deliver a serious health game supporting a lifestyle change program for diabetes prevention. As the final report under the contract, Biocentric will report on outcomes of developing and deploying a digital game to educate at-risk individuals on diabetes prevention best practices. No subcontractors or set aside designations were specified. The CDC works extensively with...
- This $149,893.46 firm fixed-price purchase order contract was awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Baker Heart and Diabetes Institute, a non-profit research organization, to conduct research on trends in the incidence of young onset Type 2 diabetes. The contract, which did not have a set-aside designation, was completed in February 2019. In addition to this prime contract, Baker Institute has also frequently served as a...
- This federal contract award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) was made to the Baker Heart And Diabetes Institute, doing business as Baker Institute, a non-profit medical research organization. The $119,000.00 fixed-price purchase order was for research on trends in the incidence of young onset Type 2 diabetes, with a completion date of August 1, 2022. The contract did not utilize a set-aside designation. While Baker Institute has...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $4,111,165.58 firm fixed-price definitive contract to Copial Business Strategists, LLC, a minority-owned, 8(a) small disadvantaged business, for administrative services in support of the Division of Diabetes Translation. The contract was awarded on January 1, 2018 and has a completion date of May 31, 2021. Copial Business Strategists specializes in business consulting services and has been...
- This is a $748,310 cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Association of State and Territorial Chronic Disease Program Directors, Inc. (ASTCDPD) to conduct a rigorous evaluation of a diabetes management program called "New Beginnings." The contract has a performance period ending on September 28, 2025. ASTCDPD is a non-profit organization that advocates for chronic disease prevention...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the effects of the COVID-19 pandemic. This contract appears to be part of the CDC's ongoing research efforts to better understand and address the burden of diabetes in the United States.
Generated 3/24/24, 5:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($804) | 11/30/23 | |
| Not listed | Not listed | $220.3k | 6/24/19 |